Education
About Us
Working with TipRanks
Follow Us
Twist Bioscience Corp (TWST)
NASDAQ:TWST
TWST Stock Chart & Stats
Day’s Range― - ―
52-Week Range$32.63 - $60.90
Previous CloseN/A
Volume152.02K
Average Volume (3M)1.24M
Market Cap
$1.96B
Enterprise Value$2.16B
Total Cash (Recent Filing)$315.20M
Total Debt (Recent Filing)$91.22M
Price to Earnings (P/E)―
Beta2.98
Next Earnings
Aug 01, 2025EPS Estimate
-0.52Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.66
Shares Outstanding59,916,140
10 Day Avg. Volume1,068,460
30 Day Avg. Volume1,236,674
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.10
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-12.27
Forecast
1Y Price Target
$47.75Price Target Upside45.67% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceContinued gross margin beats give greater confidence in the margin outlook, with gross margin well ahead of expectations.
Operational StrategyThe spin-out of the data storage business, now called Atlas Data Storage, is expected to drive operational expense savings and yield positive adjusted EBITDA.
Revenue GrowthHealthcare revenues increased by 29% year over year, driven by higher adoption of products in pharma, biotech, and diagnostic customers.
Bears Say
Market UncertaintyThere is difficulty for investors to get conviction about the durability of share gains and potential for upside given the challenging Tools and R&D end-market backdrop.
Market ValuationShares are trading at approximately 5 times EV/2026 Sales compared to about 3 times for peers, indicating that the growth outlook may already be priced into shares despite end market challenges.
Risk AssessmentThe risk/reward profile is viewed as skewed to the downside despite TWST being a market leader in an attractive niche.
---
Ownership Overview
3.23% Insiders
27.71% Mutual Funds
0.09% Other Institutional Investors
39.94% Public Companies and
Individual Investors
TWST FAQ
What was Twist Bioscience Corp’s price range in the past 12 months?
Twist Bioscience Corp lowest stock price was $32.63 and its highest was $60.90 in the past 12 months.
What is Twist Bioscience Corp’s market cap?
Twist Bioscience Corp’s market cap is $1.96B.
When is Twist Bioscience Corp’s upcoming earnings report date?
Twist Bioscience Corp’s upcoming earnings report date is Aug 01, 2025 which is in 84 days.
How were Twist Bioscience Corp’s earnings last quarter?
Twist Bioscience Corp released its earnings results on May 05, 2025. The company reported -$0.66 earnings per share for the quarter, missing the consensus estimate of -$0.548 by -$0.112.
Is Twist Bioscience Corp overvalued?
According to Wall Street analysts Twist Bioscience Corp’s price is currently Undervalued.
Does Twist Bioscience Corp pay dividends?
Twist Bioscience Corp does not currently pay dividends.
What is Twist Bioscience Corp’s EPS estimate?
Twist Bioscience Corp’s EPS estimate is -0.52.
How many shares outstanding does Twist Bioscience Corp have?
Twist Bioscience Corp has 59,916,140 shares outstanding.
What happened to Twist Bioscience Corp’s price movement after its last earnings report?
Twist Bioscience Corp reported an EPS of -$0.66 in its last earnings report, missing expectations of -$0.548. Following the earnings report the stock price went down -8.435%.
Which hedge fund is a major shareholder of Twist Bioscience Corp?
Currently, no hedge funds are holding shares in TWST
---
Twist Bioscience Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$47.75 (45.67% Upside)
$47.75 (45.67% Upside)
Blogger Sentiment
Bullish
TWST Sentiment 87%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 110.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $156.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 3.7%
Last 30 Days ▼ 3.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-26.68%
12-Months-Change
Fundamentals
Return on Equity
-38.22%
Trailing 12-Months
Asset Growth
-15.26%
Trailing 12-Months
Company Description
Twist Bioscience Corp
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California.
---
TWST Company Deck
---
TWST Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a positive outlook with record revenue growth, strategic spinout of the DNA data storage segment, and improved gross margins. While there are some market uncertainties particularly in tariffs and NIH funding, the company's strong performance across its main segments and strategic initiatives provide an optimistic view.Read More>---
TWST Stock 12 Month Forecast
Average Price Target
$47.75
▲(45.67% Upside)
Technical Analysis
---